Abstract
Purpose: Clinical trials have shown improvements in local control with the addition of a high dose rate brachytherapy boost to external beam radiotherapy in the treatment of higher risk prostate cancer [1,2]. We reviewed the 5-year outcomes of a cohort of patients treated within a single UK centre to examine biochemical progression free survival, overall survival and toxicity.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
